Advertisement
Singapore markets close in 5 hours 11 minutes
  • Straits Times Index

    3,277.15
    -15.98 (-0.49%)
     
  • Nikkei

    37,818.11
    -641.97 (-1.67%)
     
  • Hang Seng

    17,267.23
    +65.96 (+0.38%)
     
  • FTSE 100

    8,040.38
    -4.43 (-0.06%)
     
  • Bitcoin USD

    64,381.93
    -2,263.40 (-3.40%)
     
  • CMC Crypto 200

    1,391.42
    -32.68 (-2.29%)
     
  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     
  • Dow

    38,460.92
    -42.77 (-0.11%)
     
  • Nasdaq

    15,712.75
    +16.11 (+0.10%)
     
  • Gold

    2,321.10
    -17.30 (-0.74%)
     
  • Crude Oil

    82.83
    +0.02 (+0.02%)
     
  • 10-Yr Bond

    4.6520
    +0.0540 (+1.17%)
     
  • FTSE Bursa Malaysia

    1,571.50
    +0.02 (+0.00%)
     
  • Jakarta Composite Index

    7,148.04
    -26.49 (-0.37%)
     
  • PSE Index

    6,583.24
    +10.49 (+0.16%)
     

Opdivo: Growth Trajectory in Lung Cancer Indication

Opdivo: Growth Trajectory in Lung Cancer Indication

Bristol-Myers Squibb’s (BMY) Opdivo reported total revenues of $1.79 billion in the third quarter, which is a rise of 42% YoY (year-over-year). Among the revenues, the company earned $1.14 billion from the sale of Opdivo in the US market, which is a rise of 47% YoY.